Methods

Data Source
We identified patients who underwent elective cranial surgery between 2006 and 2011 using the American College of Surgeons' NSQIP database. Detailed description of the NSQIP database, including design, sampling strategy, and variable definitions, can be found elsewhere. 1, 15 The study was approved by the Cleveland Clinic Institutional Review Board.
Study Sample
We used the Current Procedural Terminology (CPT) to identify 7867 adult patients 18 years of age and older who underwent cranial surgery between 2006 and 2011. We excluded 1291 patients who had an emergency procedure as defined in the NSQIP database, because these patients were presumably treated irrespective of their anemia status. The final study sample consisted of 6576 patients with a defined preoperative hematocrit level who underwent elective cranial surgery. Approximately onethird of the patients (n = 2537) underwent craniotomy for definitive resection of a malignant brain tumor, excluding patients who underwent biopsy alone.
Anemia Categories
Using preoperative hematocrit levels, anemia was categorized according to levels established in several other studies: 19, 25 severe (hematocrit < 26%), moderate (26% to < 30%), mild (30% to < 38%), and no anemia (≥ 38%). Because the number of patients grouped in the severe anemia category was small, we combined these patients with those with moderate anemia, a group hereby referred to as "moderate-severe."
Demographics and Outcomes of Interest
All available preoperative and intraoperative factors that had been previously identified as having an effect on postoperative outcomes 3, 5, 10, 19, 20, 30 were analyzed (Table 1) . Postoperative complications, defined as occurring within 30 days of surgery, were assessed for each patient group (moderate-severe or mild anemia, and no anemia). Prolonged hospital length of stay (LOS) was defined as a longer stay than that of 75% of the patients in the sample, which was 8 days. Minor complications consisted of 1 or more of the following: superficial surgical-site infection, urinary tract infection, deep venous thrombosis, or thrombophlebitis. Major complications were considered 1 or more of the following: deep incision surgical-site infection, organ or space surgical-site infection, wound disruption, pneumonia, unplanned intubation, pulmonary embolism, greater than 48-hour postoperative ventilator-assisted respiration, progressive renal insufficiency, acute renal failure, cardiovascular accident with neurological deficit, coma of more than 24 hours, peripheral nerve injury, cardiac arrest requiring cardiopulmonary resuscitation, myocardial infarction, graft, prosthesis or flap failure, sepsis, septic shock, and/or 30-day return to the operating room (OR). Any complication was defined as having at least 1 or more minor or major complication. Return to the OR, defined as any unplanned return to the OR for a surgical procedure, and mortality were also assessed.
Statistical Analyses
Preoperative, intraoperative, and 30-day outcomes were compared between each category of anemia (moderate-severe, mild) and no anemia using the Pearson chi-square test for categorical variables and ANOVA for continuous variables. Propensity scores, including all variables from Table 1 , were generated to obtain an approximately unbiased measure of the association between anemia categories and adverse outcomes.
22 A 1:1 greedy matching technique 4 was first used to separately match the patients in each anemia group (moderate-severe, mild) with a unique patient with no anemia on propensity score. Restrictions were set on the matching criteria to allow for increased accuracy in matching. Covariates were compared between anemia groups in the matched sample. Logistic regression analysis was used to test whether different levels of anemia were independently associated with adverse outcomes. Covariates that remained unbalanced after matching on propensity scores were included in the final models. Sensitivity analyses were conducted, excluding patients that underwent intraoperative or postoperative transfusion, and repeating all analyses separately for patients with and without preoperative cardiovascular comorbidities. In addition, all analyses were repeated using preoperative hematocrit level as the predictor variables as well as limiting the study sample to patients who underwent craniotomy for definitive resection of a malignant brain tumor. A p value < 0.05 was considered statistically significant. The statistical program SAS (version 9.2, SAS Institute) was used for statistical analyses.
Results
Of the 6576 patients who underwent elective cranial surgery, 175 (2.7%) had moderate-severe anemia, and 1868 (28.4%) had mild anemia. Baseline patient characteristics are shown in Table 1 , including demographics, comorbidities, and laboratory values. The 5 most commonly performed cranial procedures listed in Table 2 comprised 65% of the sample. Anemic patients, regardless of the severity of anemia, were more likely to be older, female, nonwhite, functionally dependent, have a higher American Society of Anesthesiologists (ASA) classification, suffer from comorbidities, and have abnormal preoperative laboratory values.
The mean length of hospitalization postoperatively was 3.9 days among all patients. Patients with no anemia had the shortest LOS (median 4.0 days), followed by the mild (median 6.0 days) and moderate-severe (median 9.0 days) groups. Patients with moderate-severe anemia experienced a prolonged LOS (> 8.0 days) more frequently (n = 98, 56.0%) than other patient groups (Table 3 ). In the 30-day postoperative period, 17.1% of all patients (n = 1125) experienced at least 1 complication, 6.3% (n = 413) returned to the OR, and 2.5% (n = 162) died. Patients with moderate-severe anemia experienced more postoperative complications (24.6%, n = 43), more frequent return to the OR within 30 days (n = 14, 8.0%), and a higher 30- day mortality (n = 17, 9.7%) than patients with mild or no anemia (Table 3) . We were able to directly match 92% of patients with moderate-severe anemia and 92% of patients with mild anemia to nonanemic patients (Table 4 ). After matching, sex and abnormal platelet count remained significantly different for patients with moderate-severe anemia compared with the nonanemia group. However, between the mildly anemic and nonanemic groups, only abnormal platelet count was persistently different after matching ( Table 4) .
The relationship between anemia and each outcome of interest was determined using logistic regression before and after matching, and further including transfusion status and all unbalanced covariates. In unmatched analyses, anemia of any severity was significantly associated with prolonged LOS, increased postoperative complications, and higher 30-day mortality (Table 5) . Patients with mild anemia were also more likely to return to the OR within 30 days of the initial neurosurgical procedure, an effect that disappeared upon removing transfused patients.
After stratification using propensity scores, adverse outcomes were no more likely in patients with anemia than in those without it, although patients in the former group continued to have higher odds for prolonged LOS (Table 5 ). Removing transfused patients and accounting for unbalanced covariates, in the case of the mild anemia group, did not affect the statistical analyses (Table  5) . Similar results were found in patients who underwent craniotomy for definitive resection of a malignant brain tumor (data not shown). In sensitivity analyses, the effect of anemia was no worse in patients with or without cardiovascular comorbidities (data not shown).
Discussion
In this analysis of prospectively collected data of more than 6500 patients, those with preoperative anemia who underwent elective cranial surgery had increased odds for 30-day postoperative morbidity, mortality, and prolonged LOS. After matching on propensity scores, all levels of anemia were associated with prolonged LOS, but not complications or death. Patients with moderate-severe anemia did not have substantially poorer outcomes compared with patients with mild anemia. These findings persisted when adjusted for both the presence of cardiovascular comorbidities and transfusion status. In sensitivity analyses, patients who underwent craniotomy for tumor resection also had prolonged LOS only. Therefore, anemia was an independent risk factor for prolonged LOS in patients undergoing elective cranial surgery. 
Interpretation of Results
Anemia can be a marker of a pathophysiologically significant underlying disease process. 16 In this study, anemic patients were more likely to have concomitant comorbidities than their nonanemic counterparts. Therefore, in unmatched analyses, the significant odds ratio for postoperative complications in anemic patients reflects differences in baseline health characteristics of the 3 patient populations (moderate-severe and mild anemia vs no anemia) in addition to anemia status. The use of propen- Table 5 for each anemia group respectively.
sity score matching allowed us to assess the impact of anemia alone. In some surgical populations, it has been suggested that the association of preoperative anemia and postoperative adverse outcomes depends on the hematocrit level at the time of surgery, although not all studies concur. 5, 10, 16, 19 The odds ratios for prolonged LOS were comparable between the mild and moderate-severe anemia groups, which suggests that the degree of anemia was not strongly related to postoperative outcomes in the population of patients who underwent elective cranial surgery. However, because we pooled patients with severe anemia with those with moderate anemia due to the small number of patients with hematocrits < 26%, it is possible that the impact of severely low hematocrit was masked. Thus, we cannot generalize the findings of this study to the most severely anemic patients. Increased odds for prolonged LOS in the absence of a correlation between anemia and postoperative complications raises the question of why anemic patients are staying in the hospital longer. As shown in Table 3 , although complications are more frequent in more severely anemic patients, the absolute number of patients with anemia who experience complications is low. This reduces the power of analysis of a relationship between anemia and postoperative morbidity. We suspect that in an analysis that possessed greater statistical power, anemia would be associated with increased odds for postoperative complications as well as prolonged LOS.
In patients who undergo a craniotomy to resect a malignant tumor, because morbidity and mortality have been suggested to be higher than for patients undergoing cranial surgery for other conditions, 17 we examined the relationship between anemia and postoperative outcomes in a large subgroup of patients (n = 2537). Anemia was associated with prolonged LOS, suggesting that these patients are equally prone to adverse consequences of low hemoglobin.
Anemia and the Brain
Due to its substantial metabolic requirements, neuronal tissue has strict oxygen requirements. Because nearly all the oxygen in blood is carried bound to hemoglobin, the brain is vulnerable to anemia. Changes in both the oxygen extraction ratio 18 and regional alterations in cerebral blood flow due to autoregulation may compensate for poor oxygen delivery secondary to low hemoglobin, although a lower limit of hematocrit that can be tolerated universally has not been fully established. 11, 12, 18, 27 Thus, studying the impact of anemia in patients who undergo a neurosurgical intervention, such as craniotomy, is clinically relevant.
Anemia in Neurosurgical Patients
Anemia has been studied in the context of some neurological emergencies. Sampson et al. 23 reported anemia to be associated with an increased risk of symptomatic vasospasm in patients after aneurysmal subarachnoid hemorrhage. Wartenberg and Mayer 29 reported poorer 3-month outcome following aneurysmal subarachnoid hemorrhage in patients who were anemic. Evidence to link anemia to poor outcome in traumatic brain injury is, however, more variable. Duane et al. 9 reported that anemia correlated with greater mortality. In a case report, Cothren et al. 7 reported an acceptable outcome in an anemic Jehovah's Witness patient with severe head injury who was treated with blood substitutes and erythropoietin. Schirmer-Mikalsen et al.
24 did not find a statistically significant relationship between anemia and outcome on the Glasgow Outcome Scale.
Patients with subarachnoid hemorrhage and traumatic brain injury often develop anemia as a result of the intensive care required to stabilize and treat them, with associated neurological, metabolic, and hemodynamic consequences that lead to anemia, and they have not necessarily undergone a neurosurgical procedure as part of their treatment. Preoperative anemia as an independent risk factor for postoperative outcomes has not been studied in patients who undergo elective cranial surgery. Suess et al.
26
reported acceptable postoperative outcomes in Jehovah's Witness patients undergoing neurosurgical procedures, although hospital LOS was prolonged. This study was primarily designed to address the question of whether refusal of transfusion affects postoperative outcome in Jehovah's Witness patients; however, the patients did not have preoperative anemia.
Anemia in Nonneurosurgical Patients
Preoperative anemia has been shown to correlate with poor outcomes in various surgical patients. Leichtle et al.
19 studied the impact of preoperative anemia in 23,348 patients undergoing elective open and laparoscopic colectomies; they demonstrated that anemia of any severity predicted poorer postoperative outcomes and increased LOS. In a retrospective cohort study of 1958 adult patients undergoing surgery who refused blood transfusion, Carson et al. 5 found that compared with nonanemic patients, patients who were anemic before surgery had an increased risk of death. Wu et al.
30 found that a low hematocrit level before surgery was associated with an increased mortality rate and more frequent cardiac adverse events in 310,311 elderly veteran patients undergoing noncardiac surgery. In a single-center retrospective cohort study, Beattie et al.
3 reported a dramatic increase in postoperative mortality rate in 7759 noncardiac surgical patients.
Clinical Implications
Our analysis of 6576 patients undergoing elective cranial surgery suggests that in most cases, some degree of anemia does not affect morbidity and mortality, although substantially longer hospital stays were observed in patients with anemia. In the large subset of patients who undergo a craniotomy to resect a malignant tumor, anemia is also associated with prolonged LOS. Length of hospitalization is an important predictor of resource utilization. 6 Thus, correction of anemia may be cost-effective in patients undergoing elective cranial surgery.
While in some patients the underlying pathology may prevent correction of anemia using methods other than transfusion of blood (for example, a patient with a large tumor with cerebral edema and mass effect), in some instances resolution of the cause of the anemia, or even the administration of iron, may be adequate treatment. With respect to transfusion of blood, the potential benefits of correcting anemia must be weighed against the disadvantages of receiving blood products. Several studies have shown preoperative anemia to be strongly associated with a need for additional transfusions. 10, 14 Liberal blood transfusion, as demonstrated in the Transfusion Requirements in Critical Care trial, is predictive of poor outcomes in the intensive care setting. 13 Consequently, in our study, we removed transfused patients from our analyses to isolate the effect of anemia (Table 5) . A more restrictive transfusion strategy may circumvent the disadvantages of aggressive measures, 28 as has been suggested in case reports of Jehovah's Witness patients. 2, 26 In addition, in elective cases, more conservative alternatives of anemia treatment such as nutritional supplementation, use of ferrous sulfate or erythropoietin, 7 and correction of the underlying cause of the anemia, if possible, should be entertained when clinically permissible.
Limitations of the Study
This study has limitations. Because this is an observational study of prospectively collected data from numerous centers, it is not possible to confirm causation nor to eliminate the possibility that unobserved variables may have confounded the results. We did, however, capture and control all the covariates used in previous studies, 3, 5, 10, 19, 20, 30 and a number of additional variables that have not been evaluated elsewhere; we also controlled for transfusion during or after surgery, although the NSQIP database stopped noting the distinction between the two in 2011. 1 There is no universally accepted definition of anemia, although the WHO defined it in adults as a hemoglobin level < 12 g/dl in women and 13 g/dl in men; however, other definitions have been used, and there are no accepted criteria of the severity of anemia.
8 Furthermore, the NSQIP database does not specify the nature or origin of the anemia nor its duration prior to surgery, although some potential causes may be discerned, including alcohol use, steroids administered for chronic conditions, and cardiovascular, pulmonary, or renal comorbidities. The NSQIP database only notes the blood count performed immediately prior to surgery, which may therefore not include patients with anemia that has been corrected preoperatively, and it only contains patients who have had surgery, which may also exclude patients who, due to preexisting medical conditions (including anemia), were not offered an operation. The surgical population captured by the NSQIP may not be wholly representative of the US population of patients who undergo cranial surgery, because institutions contribute voluntarily to the database. Nonetheless, the race and gender distributions in the NSQIP are consistent with those of the US population and the data are collected prospectively from a variety of institutions, both academic and nonacademic, which provides a large, diverse sample. 15 National Surgical Quality Improvement Program data are collected in a standardized fashion, with annual quality checks and data reporting that achieves greater than 95% 30-day outcome follow-up across multiple, consecutive cycles, with accuracy and precision. 15 While anemia may result in long-term complications beyond 30 days postoperatively, our analysis nonetheless benefits from the reliability, large sample sizes, and representative nature of the NSQIP database that captures the immediate postoperative outcomes.
Conclusions
This is the first analysis of prospectively collected data reported from hospitals across the US to study the impact of preoperative anemia on postoperative outcomes and complications in patients undergoing elective cranial surgery. While preoperative anemia, irrespective of severity, was not associated with increased morbidity and mortality, it was directly associated with prolonged LOS. Thus, perioperative treatment of anemia may decrease LOS and reduce cost of care as a result.
